Stock listing

Dusseldorf:TTX Theralase Technologies Inc. Aktie

German listing (Dusseldorf) of Theralase Technologies Inc. · home listing TSXV:TLT

Follow Theralase Technologies Inc. into a list and get an email when it puts out news.

Home listing price · TSXV:TLT

$0.185 CAD -0.005 (-2.6%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSXV:TLT

Theralase Technologies Inc. logo
Ticker
Dusseldorf:TTX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Dusseldorf
Currency
EUR

What changed lately

Latest news

Theralase(R) to Present at ThinkEquity Conference

Oct 9, 2026

Correcting and Replacing: Theralase(R) Releases Q2 2026 Financial Statements

Sep 18, 2026

Theralase(R) Commences GLP Toxicology Analysis of Rutherrin(R)

Sep 15, 2026

Theralase(R) Releases Q2 2026 Financial Statements

Aug 28, 2026

Theralase(R) Closes C$3.6 Million Brokered Financing

Aug 24, 2026

Theralase(R) Announces $5 Million Brokered LIFE Offering

Aug 10, 2026

Theralase(R) Engages Global One Media to Expand Global Investor Awareness

Aug 4, 2026

Theralase(R) Receives Receipt for C$100 Million Base Shelf Prospectus

Jun 30, 2026

Theralase(R) Lists Warrants on the TSXV

Jun 3, 2026

Theralase(R) Releases Q1 2026 Financial Statements

May 29, 2026

All Theralase Technologies Inc. news

Financings

  • Private placement of units

    Sep 18, 2026

    Closed: C$3.56M in the latest tranche · C$0.24 a unit · 1 warrant at C$0.32 · Research Capital Corporation

    Dealers: Research Capital Corporation (lead)

    Insiders: An aggregate of 116,250 Units, representing gross proceeds of $27,900, were issued to certain insiders of the Company

    Use of proceeds: GLP toxicology studies for intravenous Rutherrin in cancers and topical Ruvidar for cold sores; working capital and general corporate purposes

    Announced Aug 10, 2026 · Closed Aug 24, 2026 · Closed Aug 28, 2026 · Closed Sep 18, 2026

Read by 6ix AI from the company's releases

Decks

Theralase Technologies Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
33 in the last 12 months · 241 in all · newest Oct 9, 2026 · oldest 2017
Decks
5 decks · latest Feb 17, 2026

Where Theralase Technologies Inc. is listed

ListingExchangeCountryCurrency
TSXV:TLT · Home listingTSXVCanadaCAD
OTC:TLTFFOTCUnited StatesUSD
Cboe Canada:TLTCboe CanadaCanadaCAD
Lang & Schwarz:A0DLB7Lang & SchwarzGermanyEUR
LS Exchange:A0DLB7LS ExchangeGermanyEUR
Frankfurt:TTXFrankfurtGermanyEUR
Stuttgart:TTXStuttgartGermanyEUR
Dusseldorf:TTX · This pageDusseldorfGermanyEUR

Log in to ask 6ix AI your own questions about Theralase Technologies Inc.